zolinza/vorinostat

Phase 2

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Children With Relapsed Solid Tumor, Lymphoma or Leukemia

Drug Information

Target Indication

Children With Relapsed Solid Tumor, Lymphoma or Leukemia

Clinical Trial

Last updated: 8/18/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

HPHA.DE

Heidelberg Pharma AG

Related Pipeline

Apathy in Dementia

Anaplastic Astrocytoma

Renal Cell Carcinoma

Kidney Cancer

Steroid-Dependent Nephrotic Syndrome

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts